Morris Gabriel S 4/A
4/A · Immix Biopharma, Inc. · Filed Nov 9, 2023
Insider Transaction Report
Form 4/AAmended
Morris Gabriel S
DirectorCFO
Transactions
- Award
Stock Options
2023-08-14+293,000→ 293,000 totalExercise: $1.86Exp: 2033-08-14→ Common Stock (293,000 underlying)
Footnotes (1)
- [F1]Options vest monthly over 48 months from the date of grant.